Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Peng Hu
Observed name:
Hu, Peng
Institutions:
University of Shanghai for Science and Technology,
Shanghai Jiao Tong University,
Second Affiliated Hospital of Chongqing Medical University,
Shanghai First People's Hospital,
Chongqing Medical University
Observed institutions:
University of Shanghai for Science and Technology,
Shanghai Jiao Tong University,
Second Affiliated Hospital of Chongqing Medical University,
Shanghai First People's Hospital,
Chongqing Medical University
ORCID:
0000-0001-8481-0841
Observed ORCID:
0000-0001-8481-0841
OpenAlex ID:
A5130234142
Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B
2025
·
Taiyu He
, Min Chen
, et al.
·
Gut
·
13
Liquid-liquid phase separation in cancer therapy resistance
2026
·
Peng Hu
, Huaze Ding
, et al.
·
iScience
·
5
PDF
Higher risk of postpartum phase transition to immune-active among HBeAg-positive pregnant women with indeterminate phase
2026
·
Qiao Tang
, Chun-Rui Wang
, et al.
·
Frontiers in Cellular and Infection Microbiology
·
1
PDF
CXCR5+CD8+ T cells enhance humoral immunity and contribute to antiviral activities in patients with chronic hepatitis B
2026
·
Xiaoqing Liu
, Yue Qiu
, et al.
·
Genes & Diseases
Hepatitis B virus RNA and hepatitis B surface antigen kinetics predict treatment outcomes in children with chronic hepatitis B
2026
·
Xiaorong Peng
, Yunan Chang
, et al.
·
Frontiers in Cellular and Infection Microbiology
PDF
Show more works
View as search
Works count:
16
Citation count:
19
H-index:
2
I10-index:
1
Year
Topic
Type